- 抑制劑
- 化合物庫
- 抗體
- 生物試劑
- 新產(chǎn)品
- 聯(lián)系我們
中文名稱:曲古抑菌素A
TSA (Trichostatin A) 是一種HDAC抑制劑,無細胞試驗中IC50為1.8 nM左右。
TSA (Trichostatin A) Chemical Structure
CAS: 58880-19-6
細胞系 | 實驗類型 | 給藥濃度 | 孵育時間 | 活性描述 | 文獻信息 |
---|---|---|---|---|---|
U87 GBM | Growth Inhibition Assay | 100/300/500 nM | 72 h | reduces mean cell number by 31, 54, and 58?% | 24464841 |
U87 GBM | Function Assay | 100/500 Nm | 48 h | Induces Senescence-Like Alterations in Nuclear Morphology | 24464841 |
RPE | Growth Inhibition Assay | 0.2/0.4/0.8/1 μM | 24/48/72 h | inhibits the proliferation by cell cycle arrest | 24456602 |
HT29? | Growth Inhibition Assay | 180 nM | 72 h | IC50 of 180 nM | 24368265 |
hMSCs | Function Assay | 6.25 nM | 24 h | stabilizes Histone Acetylation and the Expression of Pluripotent Genes | 24312356 |
Huh7? | Function Assay | 0.1/0.5/1.0 μM | 24h | suppresses YTHDC2 gene expression | 24269672 |
SKOV3 | Growth Inhibition Assay | 0.05-2 μM | 10/24/48 h | mediates growth arrest in a concentration- and time-dependent manner | 24223801 |
A2780 | Growth Inhibition Assay | 0.05-2 μM | 10/24/48 h | mediates growth arrest in a concentration- and time-dependent manner | 24223801 |
SRA01/04? | Growth Inhibition Assay | 0.2 μM | 48 h | suppresses cell proliferation through suppressing the PI3K/Akt, p38MAPK and ERK1/2 signaling pathways | 24157878 |
HLEB3 | Growth Inhibition Assay | 0.2 μM | 48 h | suppresses cell proliferation through suppressing the PI3K/Akt, p38MAPK and ERK1/2 signaling pathways | 24157878 |
SRA01/04? | Growth Inhibition Assay | 0.4/0.8 μM | 48 h | induces cell apoptosis | 24157878 |
HLEB3 | Growth Inhibition Assay | 0.4/0.8 μM | 48 h | induces cell apoptosis | 24157878 |
HCT116 | Growth Inhibition Assay | 0.2 μM | 12 h | enhances cell apoptosis induced by radiation | 24122231 |
CA46 | Growth Inhibition Assay | 3/6/12/24/48 nM | 48 h | inhibits the cell proliferation at 24 and 48 nM? | 24064951 |
PMNs | Function Assay | 30 nM | 48 h | inhibits efferocytosis, HDAC activity and Rac activity | 23988617 |
H1299 | Growth Inhibition Assay | 1?μM? | 24/48/72 h | increases cell death after 24h | 23916609 |
A549 | Growth Inhibition Assay | 0.25/0.5/1 μM | 24/48/72 h | inhibits the cell growth in concentration and time-dependent manner | 23867991 |
H1299 | Growth Inhibition Assay | 0.25/0.5/1 μM | 24/48/72 h | inhibits the cell growth in concentration and time-dependent manner | 23867991 |
A549 | Apoptosis Assay | 0.5/1 μM | 48 h | induces cell apoptosis | 23867991 |
H1299 | Apoptosis Assay | 0.5/1 μM | 48 h | induces cell apoptosis | 23867991 |
SUM149PT | Growth Inhibition Assay | 2/7.5/10 μM | 48 h | induces cell death at 2 μM insensitively | 23792638 |
SUM190PT | Growth Inhibition Assay | 50/100/250 nM | 48 h | induces cell death at 50 nM sensitively | 23792638 |
HCT1 | Growth Inhibition Assay | 0.2/1.0/5.0 μM | 12/24/36/48 h | induces cell death in concentration- and time-dependent manner | 23770000 |
Lovo | Growth Inhibition Assay | 0.2/1.0/5.0 μM | 12/24/36/48 h | induces cell death in concentration- and time-dependent manner | 23770000 |
Huh7 | Growth Inhibition Assay | 1 μM | 24 h | reduces about 20% viability? | 23643933 |
AGS | Growth Inhibition Assay | 0.015-1 μM | 72 h | induces cell death concentration dependently | 23745024 |
ECC1 | Function Assay | 500 nM | 5 d | induces L1CAM?expression co-treatment with 5-AzaC | 23530769 |
HEC1A | Function Assay | 500 nM | 5 d | induces L1CAM?expression co-treatment with 5-AzaC | 23530769 |
EN1 | Function Assay | 500 nM | 5 d | induces L1CAM?expression co-treatment with 5-AzaC | 23530769 |
MFE296 | Function Assay | 500 nM | 5 d | induces L1CAM?expression co-treatment with 5-AzaC | 23530769 |
HASMCs | Function Assay | 0-500 nM | 6 d | down-regulates the expression of HADC and cell viability | 23518467 |
U373 | Function Assay | 0.25/0.5/1 μM | 24 h | increases PR-B expression co-treatment with 5AzadC | 23474171 |
ARN8? | Function Assay | 0.05-2 μM | 24 h | reduces the induction of p53-dependent genes by Nutlin-3 | 23470540 |
MCF7 | Function Assay | 0.05-2 μM | 24 h | reduces the induction of p53-dependent genes by Nutlin-3 | 23470540 |
H1299? | Function Assay | 0.33–1?μM | 24/48 h | increases E-cadherin protein levels dose dependently | 23461975 |
H1299 | Function Assay | 0.5 μM | 48 h | inhibits the migratory potential combine with silibinin | 23461975 |
H1299 | Function Assay | 0.5 μM | 48 h | inhibits the invasiveness? combine with silibinin | 23461975 |
MG-63? | Growth Inhibition Assay | 0.3 μM | 12-96 h | inhibits the cell growth co-treatment with metformin | 23451817 |
LM8 | Growth Inhibition Assay | 0.3 μM | 12-96 h | inhibits the cell growth co-treatment with metformin | 23451817 |
K562 | Function Assay | 0.5 μM | 24 h | decreases the enzyme activity of HDACs co-treatment with curcumin | 23430957 |
HEL | Function Assay | 0.5 μM | 24 h | decreases the enzyme activity of HDACs co-treatment with curcumin | 23430957 |
HL60 | Apoptosis Assay | 1 μM | 24 h | induces?cell death | 23400519 |
KG1 | Apoptosis Assay | 1 μM | 24 h | induces?cell death | 23400519 |
Kazumi | Apoptosis Assay | 1 μM | 24 h | induces?cell death | 23400519 |
K562 | Apoptosis Assay | 1 μM | 24 h | induces?cell death | 23400519 |
THP1 | Apoptosis Assay | 1 μM | 24 h | induces?cell death | 23400519 |
SH-SY5Y | Function Assay | 250 nM | 16 h | changes expression pattern of genes involved in cholesterol synthesis, uptake and efflux | 23326422 |
HEK293 | Function Assay | 1 μM? | 18 h? | inhibits the kalirin-7-mediated recruitment of synphilin-1 aggregates into aggresomes | 23284848 |
HTK | Function Assay | 400 nM | 72 h | inhibits TGF-β–Induced Myofibroblast Differentiation | 23284002 |
HTK | Function Assay | 100-800nM | 72 h | blocks TGF-β–Induced ROS and H2O2?Accumulation | 23284002 |
Caco-2? | Function Assay | 1 μM? | 24 h | decreases SERT protein expression | 23195070 |
HeLa | Growth Inhibition Assay | 100 nM | 24 h | IC50 of 100nM | 23165748 |
HeLa | Growth Inhibition Assay | 40 nM | 48 h | IC50 of 40nM | 23165748 |
HeLa | Growth Inhibition Assay | 20 nM | 72 h | IC50 of 20nM | 23165748 |
HeLa | Growth Inhibition Assay | 10/30/50 nM | 72 h | increases the number of MMP (ΔΨm) loss cells dose dependently | 23165748 |
ACP03 | Growth Inhibition Assay | 250/350/500nM | 24h | decreases cell viability of approximately 70?% at 250?nM | 24668547 |
ACP02 | Growth Inhibition Assay | 250/350/500nM | 24h | decreases cell viability of approximately 70?% at 250?nM | 24668547 |
HeLa | Function Assay | 1mM | 0.5h | abolishes the total HDAC activity | 24707474 |
HMEC-1? | Function Assay | 300nM | 24h | increases expression of?VEGFR3?mRNA | 24710631 |
HeLa? | Growth Inhibition Assay | 2μM | 48h | decreases cell viability about 25% | 24846135 |
LNCaP | Growth Inhibition Assay | 100-1000nM | 24h | IC50 of 300nM | 24854658 |
PC3 | Growth Inhibition Assay | 100-1000nM | 24h | IC50 of 300nM | 24854658 |
CNE2 | Growth Inhibition Assay | 100-600nM | 24/48/72h | inhibits the proliferation in a time- and dose-dependent manner | 24969901 |
HeLa | Function Assay | 250nM | 16h | increases CYP1A1 mRNA expression? | 25116688 |
A549 | Growth Inhibition Assay | 0.01-0.9μM | 72h | IC50 of 0.06μM | 25169491 |
SKOV-3 | Growth Inhibition Assay | 0.01-0.9μM | 72h | IC50 of 0.32μM | 25169491 |
A549 | Growth Inhibition Assay | 0.1-1μM | 48h | IC50 of 0.28μM | 25169491 |
SKOV-3 | Growth Inhibition Assay | 0.1-1μM | 48h | IC50 of 0.7μM | 25169491 |
A549 | Growth Inhibition Assay | 1-10μM | 24h | IC50 of 3.2μM | 25169491 |
SKOV-3 | Growth Inhibition Assay | 1-10μM | 24h | IC50 of 5.6μM | 25169491 |
MCF7 | Growth Inhibition Assay | 0-600nM | 24h | IC50 of 75nM | 25192721 |
MDA-MB-231 | Growth Inhibition Assay | 0-600nM | 24h | IC50 of 100nM | 25192721 |
A431 | Function Assay | 50nM | 2/6/12/24h | activates p21 and inhibits ATF3 expression | 25371069 |
A431 | Apoptosis Assay | 2/10/50/100nM | 48h | inhibits the cell growth | 25371069 |
PC3? | Function Assay | 0.1μM | 48h | induces increase of HDAC1 and HDAC2 on Slug genes promoter | 25434997 |
SW480? | Function Assay | 0.1μM | 48h | induces increase of HDAC1 and HDAC2 on Slug genes promoter | 25434997 |
PC3? | Function Assay | 0.1μM | 48h | attenuates invasion and migration | 25434997 |
PC3? | Function Assay | 0.1μM | 48h | reverses EMT | 25434997 |
SW480? | Function Assay | 0.1μM | 48h | attenuates invasion and migration | 25434997 |
SW480? | Function Assay | 0.1μM | 48h | reverses EMT | 25434997 |
MEFs | Function Assay | 5μM | 16h | increases the EPEC attachment, Tir delivery and the efficiency of pedestal formation | 25482634 |
TE13 | Apoptosis Assay | 0.3μM | 24h | inhibits the cell proliferation | 25579665 |
TE13 | Function Assay | 0.3μM | 24h | up-regulates RASSF5A level | 25579665 |
HEK 293 | Function Assay | 0.7μM | 24h | enhances ENaC acetylation and increases ENaC abundance in the total cell lysate and at the cell surface | 25787079 |
MDA-MB-231 | Growth Inhibition Assay | 25-400 nM | 48 h | IC50 of 263.2nM? | 23055198 |
MCF-7? | Growth Inhibition Assay | 25-400 nM | 48 h | IC50 of 220.4nM | 23055198 |
ECC-1? | Growth Inhibition Assay | 100 nM | 24 h | increases the proportion of apoptotic nuclei to 35% | 23028803 |
HEC-1A | Growth Inhibition Assay | 100 nM | 24 h | increases the proportion of apoptotic nuclei to 39% | 23028803 |
NHAC-kn | Growth Inhibition Assay | 10/100/500 nM | 12 h | IC50 of 500nM | 23017871 |
A549 | Growth Inhibition Assay | 250 nM | 6-72 h | causes a greater inhibitory effect combine with TXT or erlotinib | 22994780 |
MG-63 | Growth Inhibition Assay | 300 nM | 12 h | inhibits the cell growth to 86% | 22799338 |
MG-63 | Growth Inhibition Assay | 300 nM | 24 h | inhibits the cell growth to 67% | 22799338 |
MG-63 | Growth Inhibition Assay | 300 nM | 48 h | inhibits the cell growth to 56% | 22799338 |
HL60? | Growth Inhibition Assay | 150-350 nM | 24 h | increases cell apoptosis?when concentrations higher than 250 nM | 22753739 |
U937 | Growth Inhibition Assay | 150-350 nM | 24 h | increases cell apoptosis?when concentrations higher than 250 nM | 22753739 |
SCC-6 | Growth Inhibition Assay | 200-3200 nM | 12/24/48 h | inhibits the proliferation of SCC-6 cells in a dose- and time-dependent manner | 22552321 |
U87? | Growth Inhibition Assay | 100-300 ng | 24 h | inhibits the cell growth to 72% at 200ng | 22270849 |
K562 | Function Assay | 1 μM | 12 h | enhances the expression of RUNX3 induced by 5-aza-CdR | 22179198 |
Reh | Function Assay | 0.3/1 μM | 12 h | enhances the expression of RUNX3 induced by 5-aza-CdR | 22179198 |
GM15850 | Function assay | 0.1 uM | 12 hrs | Inhibition of HDAC in human GM15850 cells assessed as increase in total acetylated histone level at 0.1 uM after 12 hrs by Western blot analysis | 16921367 |
HeLa | Function assay | 1 uM | 24 hrs | Induction of p16 expression in human HeLa cells at 1 uM after 24 hrs by Western blotting | 17643111 |
HeLa | Function assay | 1 uM | 24 hrs | Induction of p27 expression in human HeLa cells at 1 uM after 24 hrs by Western blotting | 17643111 |
HeLa | Function assay | 1 uM | 24 hrs | Induction of p21 expression in human HeLa cells at 1 uM after 24 hrs by Western blotting | 17643111 |
NCI-H661 | Function assay | 300 nM | 6 hrs | Inhibition of HDAC in human NCI-H661 cells assessed as induction of histone H4 acetylation at 300 nM after 6 hrs by Western blot analysis | 19385600 |
NCI-H661 | Function assay | 300 nM | 6 hrs | Inhibition of HDAC in human NCI-H661 cells assessed as induction of alpha-tubulin acetylation at 300 nM after 6 hrs by Western blot analysis | 19385600 |
HL60 | Function assay | 20 ug/ml | 24 hrs | Inhibition of HDAC in human HL60 cells assessed as increase in histone H3 acetylation at 20 ug/ml after 24 hrs by Western blot analysis | 19534471 |
MCF7 | Function assay | 0.1 uM | 16 hrs | Inhibition of SIRT2 in human MCF7 cells assessed as tubulin hyperacetylation at 0.1 uM after 16 hrs by Western blot | 20030343 |
HeLa | Function assay | 1 uM | 10 mins | Inhibition of HDAC in human HeLa cells at 1 uM after 10 mins by fluorometric assay | 21055848 |
MCF7 | Function assay | 0.5 uM | 24 hrs | Inhibition of Class 1 histone deacetylase in human MCF7 cells assessed as up-regulation of p21 protein level at 0.5 uM after 24 hrs by Western blot analysis | 22280363 |
MCF7 | Function assay | 0.5 uM | 24 hrs | Inhibition of HDAC6 in human MCF7 cells assessed as change in tubulin acetylation level at 0.5 uM after 24 hrs by Western blot analysis | 22280363 |
MCF7 | Function assay | 0.5 uM | 24 hrs | Inhibition of HDAC1 in human MCF7 cells assessed as up-regulation of acetylated histone H3 protein level at 0.5 uM after 24 hrs by Western blot analysis | 22280363 |
PC12 | Function assay | 10 uM | 48 hrs | Inhibition of HDAC6 in rat PC12 cells assessed as acetylation of histone H3 at 10 uM after 48 hrs by Western blotting analysis | 23905680 |
PC12 | Function assay | 10 uM | 48 hrs | Inhibition of HDAC6 in rat PC12 cells assessed as induction of alpha-tubulin acetylation at 10 uM after 48 hrs by Western blotting analysis | 23905680 |
PC12 | Function assay | 10 uM | 5 days | Induction of neurite outgrowth in rat PC12 cells at 10 uM after 5 days | 23905680 |
SH-SY5Y | Function assay | 10 uM | 5 days | Induction of neurite outgrowth in human SH-SY5Y cells at 10 uM after 5 days | 23905680 |
A549 | Antiproliferative assay | 0.4 uM | 24 hrs | Antiproliferative activity against human A549 cells assessed as shrunken and sharp shape at 0.4 uM after 24 hrs by phase contrast microscopy | 25884112 |
C127-LT | Function assay | 200 nM | 24 hrs | Inhibition of HDAC in mouse C127-LT cells assessed as activation of EGFP expression at 200 nM after 24 hrs by fluorescence microscopy | 26996372 |
HeLa nuclear | Function assay | 10 to 25 uM | 30 mins | Competitive inhibition of HDAC in human HeLa nuclear cells at 10 to 25 uM using Boc-acetyl-lysine-AMC as substrate after 30 mins by Lineweaver-Burk plot analysis | 26996372 |
HeLa | Function assay | 2 uM | 24 hrs | Inhibition of HDAC1 in human HeLa cells assessed as hyperacetylation of histone H3 at 2 uM incubated for 24 hrs by Western blot analysis | 27060764 |
HeLaS3 | Function assay | 10 uM | 16 hrs | Inhibition of HDAC in human HeLaS3 cells assessed as increase in histone H3K9 acetylation at 10 uM treated for 16 hrs followed by compound washout and measured up to 24 hrs by immunoblot analysis | 30258535 |
A549 | Function assay | 0.1 uM | Inhibition of SIRT2 in A549 cells assessed as ability to induce hyperacetylation of tubulin by Western blot analysis at 0.1 uM | 17149860 | |
ST14A | Function assay | 75 nM | Induction of REST/NRSF-coupled repression of luciferase tagged rat RE1/NRSE BDNF promoter activity expressed in ST14A cells at 75 nM assessed as increase in luciferase activity | 17565993 | |
HEK293 | Function assay | 600 nM | Increase in GRP78 protein level in HEK293 cells at 600 nM by immunoblot | 17566732 | |
HEK293 | Function assay | 600 nM | Increase in protein disulfide isomerase level in HEK293 cells at 600 nM by immunoblot | 17566732 | |
primary bronchial epithelial cell | Function assay | 0.1 uM | Inhibition of HDAC7 in human primary bronchial epithelial cells assessed as induction of mutant Fdelta508 CFTR protein apical surface localization at 0.1 uM | 19966789 | |
HeLaS3 | Function assay | 10 uM | Inhibition of HDAC in human HeLaS3 cells assessed as increase in histone H3K9 acetylation at 10 uM measured immediately by immunoblot analysis | 30258535 | |
Mv1Lu | Function assay | 18 hrs | Induction of wild-type p21 promoter activation in mink Mv1Lu cells after 18 hrs by luciferase assay relative to basal level, EC1000 = 0.19 μM. | 17881232 | |
HeLa | Function assay | 24 hrs | Induction of p21 expression in human HeLa cells after 24 hrs, EC1000 = 0.0115 μM. | 18397826 | |
Mv1Lu | Function assay | 24 hrs | Increase in human wild type p21 protein expression in mink Mv1Lu cells after 24 hrs by p21 promoter assay, EC1000 = 0.02 μM. | 24997578 | |
HL60 | Antiproliferative assay | 24 hrs | Antiproliferative activity against human HL60 cells after 24 hrs by MTT assay, GI50 = 0.59 μM. | 29454918 | |
MDA-MB-435 | Antiproliferative assay | 24 hrs | Antiproliferative activity against human MDA-MB-435 cells after 24 hrs by MTT assay, GI50 = 1.78 μM. | 29454918 | |
H661 | Antiproliferative assay | 48 hrs | Antiproliferative activity against H661 cells after 48 hrs by XTT assay, IC50 = 0.085 μM. | 17624773 | |
H661 | Antiproliferative assay | 48 hrs | Antiproliferative activity against H661 cells after 48 hrs, IC50 = 0.085 μM. | 17897824 | |
NCI-H661 | Antiproliferative assay | 48 hrs | Antiproliferative activity against human NCI-H661 cells after 48 hrs by XTT assay, IC50 = 0.1 μM. | 19385600 | |
HCT116 | Cytotoxicity assay | 3 days | Cytotoxicity against human HCT116 cells after 3 days by WST-1 assay, IC50 = 0.8 μM. | 20452226 | |
HCT116 | Growth inhibition assay | 48 hrs | Growth inhibition of human HCT116 cells after 48 hrs by SRB assay, IC50 = 0.043 μM. | 21073160 | |
H460 | Growth inhibition assay | 48 hrs | Growth inhibition of human H460 cells after 48 hrs by SRB assay, IC50 = 0.1 μM. | 21073160 | |
DMS53 | Cytotoxicity assay | 2 days | Cytostatic activity against human DMS53 cells assessed as inhibition of cell proliferation after 2 days by MTT assay, IC50 = 0.025 μM. | 21504214 | |
HeLa | Function assay | 20 mins | Inhibition of HDAC in human HeLa cells using Ac-Arg-Gly-Lys(Ac)-AMC as fluorescent substrate after 20 mins by fluorescence assay, IC50 = 0.003 μM. | 21621883 | |
Sf9 | Function assay | 1 hr | Inhibition of N terminal hexahistidine-tagged human HDAC8 expressed in Sf9 cells after 1 hr by fluorescence assay, IC50 = 0.96 μM. | 21723733 | |
MCF7 | Antiproliferative assay | 48 hrs | Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay, IC50 = 1.7 μM. | 22465091 | |
BE(2)-C | Antiproliferative assay | 72 hrs | Antiproliferative activity against human BE(2)-C cells after 72 hrs by Alamar blue assay, IC50 = 0.05 μM. | 22932316 | |
Sf9 | Function assay | 2 hrs | Inhibition of human recombinant HDAC6 expressed in Sf9 cells incubated for 2 hrs using RHKK-Ac fluorogenic substrate, IC50 = 0.0012 μM. | 23009203 | |
Sf9 | Function assay | 2 hrs | Inhibition of human recombinant HDAC1 expressed in Sf9 cells incubated for 2 hrs using RHKK-Ac fluorogenic substrate, IC50 = 0.005 μM. | 23009203 | |
A2780 | Cytotoxicity assay | 72 hrs | Cytotoxicity against cisplatin resistant human A2780 cells after 72 hrs by MTT assay, IC50 = 0.22 μM. | 23252603 | |
A2780 | Function assay | 18 hrs | Inhibition of HDAC in cisplatin resistant human A2780 cells after 18 hrs by fluorescence assay, IC50 = 0.25 μM. | 23252603 | |
A2780 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human A2780 cells after 72 hrs by MTT assay, IC50 = 0.29 μM. | 23252603 | |
A2780 | Function assay | 18 hrs | Inhibition of HDAC in human A2780 cells after 18 hrs by fluorescence assay, IC50 = 0.43 μM. | 23252603 | |
MOLT4 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human MOLT4 cells assessed as reduction in cell viability after 72 hrs by CCK8 assay, IC50 = 0.03 μM. | 24960627 | |
A549 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human A549 cells assessed as reduction in cell viability after 72 hrs by CCK8 assay, IC50 = 0.05 μM. | 24960627 | |
MCF7 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by CCK8 assay, IC50 = 0.06 μM. | 24960627 | |
HL60 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human HL60 cells assessed as reduction in cell viability after 72 hrs by CCK8 assay, IC50 = 0.08 μM. | 24960627 | |
BGC823 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human BGC823 cells assessed as reduction in cell viability after 72 hrs by CCK8 assay, IC50 = 0.08 μM. | 24960627 | |
HuH7 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human HuH7 cells assessed as reduction in cell viability after 72 hrs by CCK8 assay, IC50 = 0.1 μM. | 24960627 | |
U937 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human U937 cells assessed as reduction in cell viability after 72 hrs by CCK8 assay, IC50 = 0.1 μM. | 24960627 | |
HeLa | Cytotoxicity assay | 72 hrs | Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 72 hrs by CCK8 assay, IC50 = 0.11 μM. | 24960627 | |
NCI-H1975 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human NCI-H1975 cells assessed as reduction in cell viability after 72 hrs by CCK8 assay, IC50 = 0.21 μM. | 24960627 | |
K562 | Cytotoxicity assay | 72 hrs | Cytotoxicity against human K562 cells assessed as reduction in cell viability after 72 hrs by CCK8 assay, IC50 = 0.41 μM. | 24960627 | |
HEK293 | Cytotoxicity assay | 96 hrs | Cytotoxicity against human HEK293 cells after 96 hrs by MTT assay, IC50 = 0.16 μM. | 25556102 | |
LO2 | Cytotoxicity assay | 96 hrs | Cytotoxicity against human LO2 cells after 96 hrs by MTT assay, IC50 = 0.21 μM. | 25556102 | |
HeLa | Cytotoxicity assay | 96 hrs | Cytotoxicity against human HeLa cells after 96 hrs by MTT assay, IC50 = 0.85 μM. | 25556102 | |
HepG2 | Cytotoxicity assay | 96 hrs | Cytotoxicity against human HepG2 cells after 96 hrs by MTT assay, IC50 = 0.96 μM. | 25556102 | |
U2OS | Cytotoxicity assay | 96 hrs | Cytotoxicity against human U2OS cells after 96 hrs by MTT assay, IC50 = 14.93 μM. | 25556102 | |
Sf9 | Function assay | 90 mins | Inhibition of full length human recombinant N-terminal GST-tagged HDAC6 (1 to 1215 residues) expressed in sf9 cells using RHK-K(Ac)-AMC as substrate incubated for 90 mins by fluorescence assay, IC50 = 0.001716 μM. | 27060764 | |
Sf21 | Function assay | 60 mins | Inhibition of full length human recombinant C-terminal FLAG-His-tagged HDAC1 (1 to 482 residues) expressed in Sf21 cells using RHK-K(Ac)-AMC as substrate incubated for 60 mins by fluorescence assay, IC50 = 0.006574 μM. | 27060764 | |
insect cell | Function assay | 60 mins | Inhibition of full length human recombinant C-terminal GST-tagged HDAC2 (1 to 488 residues) expressed in insect cells using RHK-K(Ac)-AMC as substrate incubated for 60 mins by fluorescence assay, IC50 = 0.01051 μM. | 27060764 | |
insect cell | Function assay | 60 mins | Inhibition of full length human recombinant C-terminal His-tagged HDAC3 (1 to 428 residues)/human recombinant N-terminal GST-tagged NCOR2 expressed in insect cells using RHK-K(Ac)-AMC as substrate incubated for 60 mins by fluorescence assay, IC50 = 0.01107 μM. | 27060764 | |
insect cell | Function assay | 60 mins | Inhibition of human recombinant C-terminal His-tagged HDAC8 (1 to 377 residues) expressed in insect cells using RHK-K(Ac)-K(Ac)-AMC as substrate incubated for 60 mins by fluorescence assay, IC50 = 0.3074 μM. | 27060764 | |
SHSY5Y | Function assay | 8 hrs | Inhibition of HDAC6 in human SHSY5Y cells using BATCP as substrate after 8 hrs by UHPLC-ESI-MS/MS analysis, IC50 = 0.0078 μM. | 27650925 | |
SHSY5Y | Function assay | 8 hrs | Inhibition of HDAC in human SHSY5Y cells using MAL as substrate after 8 hrs by UHPLC-ESI-MS/MS analysis, IC50 = 0.0091 μM. | 27650925 | |
Sf9 | Function assay | 4 hrs | Inhibition of human recombinant GST-tagged HDAC1 expressed in baculovirus infected Sf9 insect cells using MOCPAC as substrate after 4 hrs by UHPLC-ESI-MS/MS analysis, IC50 = 0.0157 μM. | 27650925 | |
insect cell | Function assay | 4 hrs | Inhibition of human recombinant HDAC6 expressed in baculovirus infected insect cells using BATCP as substrate after 4 hrs by UHPLC-ESI-MS/MS analysis, IC50 = 0.016 μM. | 27650925 | |
SHSY5Y | Function assay | 8 hrs | Inhibition of HDAC1 in human SHSY5Y cells using MOCPAC as substrate after 8 hrs by UHPLC-ESI-MS/MS analysis, IC50 = 0.0188 μM. | 27650925 | |
HEK293T | Function assay | 30 mins | Inhibition of recombinant human HDAC1 expressed in HEK293T cells using Ac-KGLGK(Ac)-MCA as substrate after 30 mins in presence of DTT by fluorescence assay, IC50 = 0.019 μM. | 29519604 | |
HEK293T | Function assay | 30 mins | Inhibition of recombinant mouse HDAC6 expressed in HEK293T cells co-expressing mouse HDA2 using Ac-KGLGK(Ac)-MCA as substrate after 30 mins in presence of DTT by fluorescence assay, IC50 = 0.028 μM. | 29519604 | |
Sf9 | Function assay | 90 mins | Inhibition of full length recombinant human N-terminal GST-tagged HDAC6 expressed in baculovirus-infected Sf9 insect cells using RHKK(Ac)AMC as substrate after 90 mins by fluorimeter, Ki = 0.00058 μM. | 29589441 | |
Sf21 | Function assay | 60 mins | Inhibition of recombinant human C-terminal FLAG/His-tagged HDAC1 expressed in baculovirus-infected Sf21 insect cells using RHKK(Ac)AMC as substrate after 60 mins by fluorimeter, Ki = 0.00064 μM. | 29589441 | |
insect cell | Function assay | 60 mins | Inhibition of full length recombinant human C-terminal His-tagged HDAC3/N-terminal GST-tagged recombinant human NCOR2 (395 to 489 residues) expressed in baculovirus-infected insect cells using RHKK(Ac)AMC as substrate after 60 mins by fluorimeter, Ki = 0.00084 μM. | 29589441 | |
insect cell | Function assay | 60 mins | Inhibition of full length recombinant human C-terminal GST-tagged HDAC2 expressed in baculovirus-infected insect cells using RHKK(Ac)AMC as substrate after 60 mins by fluorimeter, Ki = 0.00355 μM. | 29589441 | |
insect cell | Function assay | 60 mins | Inhibition of recombinant human C-terminal His-tagged HDAC8 (1 to 377 residues) expressed in baculovirus-infected insect cells using RHK(Ac)K(Ac)AMC as substrate after 60 mins by fluorimeter, Ki = 0.145 μM. | 29589441 | |
HEK293 STF | Function assay | 24 hrs | Activation of mouse Wnt3a signaling expressed in HEK293 STF cells assessed as increase in transcriptional activity after 24 hrs by luciferase reporter gene-based lactate dehydrogenase assay | 19022675 | |
HN13 | Function assay | 24 hrs | Inhibition of HDAC in human HN13 cells assessed as reduction in histone H3 Lys9 acetylation incubated for 24 hrs by immunofluorescence assay | 29031066 | |
HCT 116 | Antiproliferative assay | In vitro antiproliferative activity against human colon cancer HCT 116 cells determined by MMT assay, EC50 = 1 μM. | 11597413 | ||
T24 | Function assay | Concentration of compound required for acetylation of histone-4 in human T24 cancer cells, EC50 = 1 μM. | 11597413 | ||
T24 | Function assay | Inhibition of acetylation of histone-4 in human T-24 cancer cells, EC50 = 1 μM. | 14613312 | ||
T24 | Function assay | Inhibition of acetylation of histone-4 in human T-24 cancer cells, EC50 = 4 μM. | 14613312 | ||
T24 | Function assay | Induction of alpha tubulin acetylation in human T24 cells, EC50 = 0.01 μM. | 19111466 | ||
T24 | Function assay | Induction of histone H3 acetylation in human T24 cells, EC50 = 0.01 μM. | 19111466 | ||
HepG2 | Function assay | Up-regulation of transcriptional activity of human CLA-1 promoter region -1055 to -62bp transfected in HepG2 cells by luciferase reporter gene assay, EC50 = 0.38 μM. | 25556102 | ||
HeLa | Function assay | Inhibition of HDAC6 in human HeLa cells assessed as inhibition of tubulin deacetylation incubated for overnight by cELISA, EC50 = 0.0052 μM. | 26611919 | ||
K562 | Function assay | Inhibitory activity against partially purified histone deacetylase of human leukemia K562 cells., IC50 = 0.0046 μM. | 10425110 | ||
A20 | Function assay | In vitro for anti-HDAC1 (Histone deacetylase 1) activity in mouse A20 cells, IC50 = 0.002 μM. | 11960489 | ||
K 562 | Function assay | Inhibitory activity against Histone deacetylase (HDAC) in K 562 erythroleukemia cells, IC50 = 0.0034 μM. | 14592473 | ||
friend cell | Function assay | Inhibitory concentration against friend cells proliferation, IC50 = 0.04 μM. | 14613312 | ||
SNU-16 | Function assay | Inhibitory activity against Histone deacetylase (HDAC) from SNU-16 (human gastric adenocarcinoma) cells, IC50 = 0.05329 μM. | 14667227 | ||
melanoma B16/BL6 | Function assay | Inhibitory activity against histone deacetylases (HDAC1) prepared from mouse melanoma B16/BL6 cells, IC50 = 0.019 μM. | 15109626 | ||
melanoma B16/BL6 | Function assay | Inhibitory activity against histone deacetylase (HDAC4) prepared from mouse melanoma B16/BL6 cells, IC50 = 0.02 μM. | 15109626 | ||
melanoma B16/BL6 | Function assay | Inhibitory activity against histone deacetylase 6 prepared from mouse melanoma B16/BL6 cells, IC50 = 0.028 μM. | 15109626 | ||
melanoma B16/BL6 | Function assay | Inhibitory activity against histone deacetylase 8 prepared from mouse melanoma B16/BL6 cells, IC50 = 0.04 μM. | 15109626 | ||
293T | Function assay | Inhibition of human histone deacetylase 4 prepared from 293T cells, IC50 = 0.02 μM. | 15454224 | ||
293T | Function assay | Inhibition of human histone deacetylase 1 prepared from 293T cells, IC50 = 0.02 μM. | 15454224 | ||
293T | Function assay | Inhibition of human histone deacetylase 6 prepared from 293T cells, IC50 = 0.02 μM. | 15454224 | ||
293T | Function assay | Inhibition of human histone deacetylase 8 prepared from 293T cells, IC50 = 0.04 μM. | 15454224 | ||
HeLa | Function assay | Inhibitory concentration against human histone deacetylase (HDAC) from HeLa cells with substrate 5a, IC50 = 0.0545 μM. | 15456267 | ||
HCT116 | Antiproliferative assay | Antiproliferative activity against HCT116 cells, IC50 = 0.0013 μM. | 16904890 | ||
H1299 | Antiproliferative assay | Antiproliferative activity against H1299 cells, IC50 = 0.1 μM. | 16904890 | ||
H661 | Antiproliferative assay | Antiproliferative activity against H661 cells, IC50 = 0.3 μM. | 16904890 | ||
WiDr | Growth inhibition assay | Inhibition of SAP130 mediated cell growth in human WiDr cells, IC50 = 0.5776 μM. | 17643112 | ||
U251 | Function assay | Inhibition of SAP130 in VEGF-stimulated human U251 cells by PLAP reporter gene assay, IC50 = 0.6112 μM. | 17643112 | ||
293T | Function assay | Inhibition of human HDAC1 expressed in 293T cells, IC50 = 0.0019 μM. | 17881232 | ||
293T | Function assay | Inhibition of human HDAC4 expressed in 293T cells, IC50 = 0.002 μM. | 17881232 | ||
293T | Function assay | Inhibition of mouse HDAC6 expressed in 293T cells, IC50 = 0.0028 μM. | 17881232 | ||
293T | Function assay | Inhibition of HDAC1 expressed in 293T cells, IC50 = 0.19 μM. | 17900911 | ||
293T | Function assay | Inhibition of HDAC4 expressed in 293T cells, IC50 = 0.2 μM. | 17900911 | ||
293T | Function assay | Inhibition of HDAC6 expressed in 293T cells, IC50 = 0.28 μM. | 17900911 | ||
NIH3T3 | Function assay | Inhibition of human recombinant HDAC1 expressed in NIH3T3 cells, IC50 = 0.021 μM. | 17929798 | ||
human 293 | Function assay | Inhibition of human recombinant HDAC4 expressed in 293 cells, IC50 = 0.034 μM. | 17929798 | ||
mouse 293 | Function assay | Inhibition of mouse recombinant HDAC6 expressed in 293 cells, IC50 = 0.081 μM. | 17929798 | ||
SKBR3 | Antiproliferative assay | Antiproliferative activity against human SKBR3 cells, IC50 = 0.02 μM. | 18247554 | ||
MM96L | Function assay | Inhibition of human MM96L cells, IC50 = 0.03 μM. | 18247554 | ||
SNU16 | Function assay | Inhibition of HDAC from human SNU16 cells, IC50 = 0.053 μM. | 18247554 | ||
A549 | Antiproliferative assay | Antiproliferative activity against human A549 cells, IC50 = 0.08 μM. | 18247554 | ||
MKN45 | Antiproliferative assay | Antiproliferative activity against human MKN45 cells, IC50 = 0.1 μM. | 18247554 | ||
SQ20B | Function assay | Inhibition of human SQ20B cells, IC50 = 0.2 μM. | 18247554 | ||
neonatal foreskin fibroblasts | Growth inhibition assay | Growth inhibition of human neonatal foreskin fibroblasts cells, IC50 = 0.2 μM. | 18247554 | ||
HeLa | Function assay | Inhibition of HDAC from human HeLa cells, IC50 = 0.3 μM. | 18247554 | ||
MM96L/NFF | Function assay | Selectivity index, ratio of IC50 for human MM96L cells to IC50 for human NFF cells, IC50 = 6.7 μM. | 18247554 | ||
293T | Function assay | Inhibition of human HDAC1 expressed in 293T cells, IC50 = 0.0366 μM. | 18397826 | ||
293T | Function assay | Inhibition of human HDAC4 expressed in 293T cells, IC50 = 0.0629 μM. | 18397826 | ||
293T | Function assay | Inhibition of human HDAC6 expressed in 293T cells, IC50 = 0.0833 μM. | 18397826 | ||
HeLa | Function assay | Inhibition of human HDAC in HeLa cells by flour de lys assay, IC50 = 0.005 μM. | 18397827 | ||
S2 | Function assay | Inhibition of Plasmodium falciparum HDAC1 expressed in Drosophila melanogaster S2 cells, IC50 = 0.0006 μM. | 19317450 | ||
NIH3T3 | Function assay | Inhibition of HDAC1 in human NIH3T3 cells by radiometric histone deacetylation assay, IC50 = 0.006 μM. | 19457659 | ||
HeLa | Function assay | Inhibition of HDAC from human HeLa cells by fluorogenic enzyme assay, IC50 = 0.3 μM. | 19457659 | ||
ML1 | Antitumor assay | Antitumor activity against mouse ML1 cells, IC50 = 0.25 μM. | 19534534 | ||
Sf9 | Function assay | Inhibition of human recombinant HDAC6 expressed in baculovirus/sf9 cells using RHKKAc as substrate, IC50 = 0.0009 μM. | 23905680 | ||
Sf9 | Function assay | Inhibition of human recombinant HDAC1 expressed in baculovirus/sf9 cells using RHKKAc as substrate, IC50 = 0.005 μM. | 23905680 | ||
Sf9 | Function assay | Inhibition of human recombinant HDAC2 expressed in baculovirus/sf9 cells using RHKKAc as substrate, IC50 = 0.005 μM. | 23905680 | ||
Sf9 | Function assay | Inhibition of human recombinant HDAC10 expressed in baculovirus/sf9 cells using RHKKAc as substrate, IC50 = 0.009 μM. | 23905680 | ||
Sf9 | Function assay | Inhibition of human recombinant HDAC11 expressed in baculovirus/sf9 cells using RHKKAc as substrate, IC50 = 0.0173 μM. | 23905680 | ||
Sf9 | Function assay | Inhibition of human recombinant HDAC8 expressed in baculovirus/sf9 cells using RHKAcKAc as substrate, IC50 = 0.129 μM. | 23905680 | ||
insect cell | Function assay | Inhibition of human recombinant N-terminal His-tagged HDAC11 (1 to 347 residues) expressed in insect cells/baculovirus expression system using RHK-K(Ac)-AMC as substrate by fluorescence assay, IC50 = 0.01137 μM. | 27060764 | ||
NFF | Cytotoxicity assay | Cytotoxicity against human NFF cells, IC50 = 0.2 μM. | 30245402 | ||
insect cell | Function assay | Inhibition of N-terminal GST-tagged recombinant human HDAC6 expressed in baculovirus infected insect cells using RHKK(Ac)AMC as substrate by fluorescence-based assay, IC50 = 0.0085 μM. | 30365892 | ||
Sf21 | Function assay | Inhibition of C-terminal FLAG-His-tagged full length recombinant human HDAC1 expressed in Sf21 insect cells using RHKK(Ac)AMC as substrate by fluorescence-based assay, IC50 = 0.0094 μM. | 30365892 | ||
insect cell | Function assay | Inhibition of recombinant human HDAC3/NCOR2 expressed in baculovirus infected insect cells using RHKK(Ac)AMC as substrate by fluorescence-based assay, IC50 = 0.0127 μM. | 30365892 | ||
insect cell | Function assay | Inhibition of C-terminal GST-tagged recombinant human HDAC2 expressed in baculovirus infected insect cells using RHKK(Ac)AMC as substrate by fluorescence-based assay, IC50 = 0.0267 μM. | 30365892 | ||
insect cell | Function assay | Inhibition of C-terminal His-tagged recombinant human HDAC8 expressed in baculovirus infected insect cells using RHKK(Ac)AMC as substrate by fluorescence-based assay, IC50 = 0.609 μM. | 30365892 | ||
A20 | Function assay | Binding affinity towards HDAC1 (Histone deacetylase 1) in mouse A20 cells, expressed as binding constant (pKi), Ki = 0.001072 μM. | 11960489 | ||
Hela | Function assay | Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay, Ki = 0.504 μM. | 19520580 | ||
insect cell | Function assay | Inhibition of recombinant human HDAC10 expressed in baculovirus-infected insect cells using fluorogenic peptide RHKKAc as substrate by fluorimeter, Ki = 0.00476 μM. | 29589441 | ||
insect cell | Function assay | Inhibition of recombinant human N-terminal His-tagged HDAC11 (1 to 347 residues) expressed in baculovirus-infected insect cells using RHKK(Ac)AMC as substrate by fluorimeter, Ki = 0.401 μM. | 29589441 | ||
HCT116 | Function assay | Inhibition of human HDAC1 assessed as histone hyperacetylation in human HCT116 cells by Western blot | 18054239 | ||
HCT116 | Function assay | Inhibition of human HDAC6 assessed as tubulin hyperacetylation in human HCT116 cells by Western blot | 18054239 | ||
HeLa | Function assay | Inhibition of HDAC6 in human HeLa cells assessed as tubulin acetylation incubated for overnight by immunofluorescence microscopic analysis | 26611919 | ||
點擊查看更多細胞系數(shù)據(jù) |
產(chǎn)品描述 | TSA (Trichostatin A) 是一種HDAC抑制劑,無細胞試驗中IC50為1.8 nM左右。 | ||
---|---|---|---|
靶點 |
|
體外研究(In Vitro) | ||||
體外研究活性 | Trichostatin A 抑制八種乳腺癌細胞系,包括MCF-7, T-47D, ZR-75-1, BT-474, MDA-MB-231, MDA-MB-453, CAL 51, 和 SK-BR-3增殖,平均IC50為124.4 nM (范圍為26.4-308.1 nM),作用于表達ERα的細胞系比作用于表達 ERα陰性的細胞系更有效。Trichostatin A作用于全部乳腺癌細胞系,抑制HDAC活性,平均IC50為 2.4 nM (范圍為0.6-2.6 nM), 產(chǎn)生顯著的組蛋白 H4高度乙?;?sup>[1]與 Trapoxin (TPX) 和 Chlamydocin 有效抑制HDAC1 或 HDAC4而不是 HDAC6不同,Trichostatin A 抑制這些HDACs,且抑制程度相似, IC50 分別為6 nM, 38 nM, 和8.6 nM。[2] Trichostatin A (100 ng/mL) 作用于MIA PaCa-2細胞,通過招募p300和 PCAF進入Sp1-NF-Y HDAC復合體,而誘導轉(zhuǎn)化生長因子βⅡ型受體(TβRII) 表達,復合體與TβRII 啟動子的DNA片段結(jié)合,伴隨著Sp1乙?;遗c復合體相關(guān)的HDAC數(shù)理全部降低。[4] | |||
---|---|---|---|---|
激酶實驗 | 體外HDAC活性 | |||
從每種乳腺癌細胞系(MCF-7, T-47D, ZR-75-1, BT-474, MDA-MB-231, MDA-MB-453, CAL 51,或 SK-BR-3)中準備全部細胞提取物。在溶于0.1% (v/v)乙醇的不同濃度Trichostatin A存在時,或者使用0.1% (v/v)乙醇作為對照, 20 μL 細胞粗提取物(~2.5 ×105 個細胞)與 1 μL ~1.5 × 106 cpm [3H]乙酰標記的組蛋白 H4 肽底物(第2-20位NH2-末端殘基) 在25oC下溫育60分鐘。使用50 μL 1 M HCl/0.16 M 乙酸對每組 200-μL 反應進行淬火,然后使用600 μL 乙酸乙酯進行抽提,通過閃爍計數(shù)器測量釋放的[3H]乙酸。使用非線性回歸曲線擬合抑制數(shù)據(jù),繪制合適的劑量反應曲線,而測定IC50。 | ||||
細胞實驗 | 細胞系 | MCF-7, T-47D, ZR-75-1, BT-474, MDA-MB-231, MDA-MB-453, CAL 51, 和 SK-BR-3 | ||
濃度 | 溶于無水酒精,終濃度為~10 μM | |||
孵育時間 | 96小時 | |||
方法 | 使用不同濃度Trichostatin A處理細胞96小時。處理后,使用sulforhodamine B 比色分析測定細胞增殖。通過臺酚藍染色排除法測定細胞活力。 | |||
實驗圖片 | 檢測方法 | 檢測指標 | 實驗圖片 | PMID |
Western blot | EGFR / STAT3 Cyclin D1 / CDK6 / CDK4 / p-RB / RB MMP-1 / MMP-3 / MMP-13 / TIMP-1 Acetyl-H3 (Lys27) / H3 (96C10) / Acetyl-H4(Lys8) / H4(L64C1) α-H3Ac / α-H4Ac / α-H3K9Ac / α-H3K9 S10 / α-H3K4 me / α-H3K4 me2 / α-H3K9 me2 |
![]() |
31289542 | |
Immunofluorescence | α-C/EBPβ / α-HP1α α-HDAC1 α-tubulin / acetylated histone 3 |
![]() |
21122806 | |
Growth inhibition assay | Cell viability (A549 cells) Cell viability (MDA-MB-231 cells) Cell viability (PC3 cells) |
![]() |
27571418 |
體內(nèi)研究(In Vivo) | ||
體內(nèi)研究活性 | Administration of Trichostatin A 按 0.5 mg/kg 劑量處理N-甲基-N-亞硝基脲致癌物誘發(fā)的大鼠乳腺癌模型,持續(xù)處理4周,具有有效的抗癌活性,即使按按高達5 mg/kg劑量處理也沒有任何可測量到的毒性。[1]Trichostatin A 按10 mg/kg 劑量單獨腹腔注射給藥非轉(zhuǎn)基因和脊髓性肌萎縮癥(SMA)模型鼠,導致乙?;?H3 和 H4組蛋白水平提高,也導致活運動神經(jīng)元(SMN) 基因表達稍微提高。Trichostatin A 每天按10 mg/kg劑量處理SMA模型鼠,促進存活, 減輕體重下降,且增強運動行為。[5] | |
---|---|---|
動物實驗 | Animal Models | 攜帶NMU誘導的腫瘤的近交系(Ludwig/Wistar/Olac)處女鼠 |
Dosages | ~5 mg/kg/day | |
Administration | 皮下注射 |
NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
---|---|---|---|---|---|
NCT05355363 | Recruiting | Colorectal Cancer|Colon Adenoma |
Centre hospitalier de l''Université de Montréal (CHUM) |
February 27 2023 | Not Applicable |
NCT05414890 | Recruiting | NMO Spectrum Disorder|NMDA-R Encephalitis|Diagnostic Self Evaluation|Immune System Diseases|Nervous System Diseases|Autoimmune Diseases of the Nervous System|Autoimmune Diseases |
Beijing Tiantan Hospital|Tianjin Medical University General Hospital |
June 30 2022 | -- |
NCT05271955 | Not yet recruiting | Autism Spectrum Disorder |
Assistance Publique - H?pitaux de Paris|University Hospital Montpellier |
June 15 2022 | Not Applicable |
NCT04606771 | Active not recruiting | Non-Small Cell Lung Cancer |
AstraZeneca |
September 28 2020 | Phase 2 |
NCT03877510 | Completed | Parkinson Disease |
Impax Laboratories LLC |
April 3 2019 | Phase 3 |
分子量 | 302.4 | 分子式 | C17H22N2O3 |
CAS號 | 58880-19-6 | SDF | Download TSA (Trichostatin A) SDF |
Smiles | CC(C=C(C)C=CC(=O)NO)C(=O)C1=CC=C(C=C1)N(C)C | ||
儲存條件(自收到貨起) | |||
體外溶解度 |
DMSO : 60 mg/mL ( (198.41 mM) ;DMSO吸濕會降低化合物溶解度,請使用新開封DMSO) Water : Insoluble |
摩爾濃度計算器 |
體內(nèi)溶解度 現(xiàn)配現(xiàn)用,請按從左到右的順序依次添加,澄清后再加入下一溶劑 |
動物體內(nèi)配方計算器 |
動物體內(nèi)配方計算器(澄清溶液)
第一步:請輸入基本實驗信息(考慮到實驗過程中的損耗,建議多配一只動物的藥量)
第二步:請輸入動物體內(nèi)配方組成(配方適用于不溶于水的藥物;不同批次藥物配方比例不同,請聯(lián)系Selleck為您提供正確的澄清溶液配方)
計算結(jié)果:
工作液濃度: mg/ml;
DMSO母液配制方法: mg 藥物溶于μL DMSO溶液(母液濃度mg/mL,注:如該濃度超過該批次藥物DMSO溶解度,請先聯(lián)系Selleck);
體內(nèi)配方配制方法:取μL DMSO母液,加入μL PEG300,混勻澄清后加入μL Tween 80,混勻澄清后加入μL ddH2O,混勻澄清。
體內(nèi)配方配制方法:取μL DMSO母液,加入μL Corn oil,混勻澄清。
注意:1. 首先保證母液是澄清的;
2.一定要按照順序依次將溶劑加入,進行下一步操作之前必須保證上一步操作得到的是澄清的溶液,可采用渦旋、超聲或水浴加熱等物理方法助溶。
在訂購、運輸、儲存和使用我們的產(chǎn)品的任何階段,您遇到的任何問題,均可以通過撥打我們的熱線電話400-668-6834,或者技術(shù)支持郵箱tech@selleck.cn,直接聯(lián)系到我們。我們會在24小時內(nèi)盡快聯(lián)系您。
如果有其他問題,請給我們留言。
* 必填項
問題 1:
I would like to obtain the enantiomers of TSA, as separate chemicals: R-TSA and S-TSA. Do you have any ideas?
回答:
Our S1045 Trichostatin A (TSA) is R enantiomer.